Meeta Madhani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meeta Madhani has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alice Caroline Smith
Affiliations Leicester Kidney Lifestyle Team, Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom, Leicester NIHR Biomedical Research Centre, Leicester, United Kingdom
1 shared publication - Anthony Locke
Aging Related Research Patient and Public Involvement Group, University of Leicester, Leicester LE1 7RH, UK
1 shared publication - Emma Regen
Department of Health Sciences, University of Leicester, Leicester, UK
1 shared publication - Hannah Mary Louise Young
Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK
1 shared publication - James O. Burton
University of Hospitals of Leicester NHS Trust , Leicester
1 shared publication - Kay Phelps
Department of Health Sciences, University of Leicester, Leicester, UK
1 shared publication
Latest Publications
- Open Access
- 6 October 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (19) , 3756
Co-producing Progression Criteria for Feasibility Studies: A Partnership between Patient Contributors, Clinicians and Researchers
There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We describe a process for co-producing PC for an ongoing feasibility study. Patient contributors, clinicians and researchers participated in discussions facilitated using the modified Nominal Group Technique (NGT). Stage one involved individual discussion groups used to develop and rank PC for aspects of the trial key to feasibility. A second stage involving representatives from each of the individual groups then discussed and ranked these PC. The highest ranking PC became the criteria used. At each stage all members were provided with a brief education session to aid understanding and decision-making. Fifty members (15 (29%) patients, 13 (25%) researchers and 24 (46%) clinicians) were involved in eight initial groups, and eight (two (25%) patients, five (62%) clinicians, one (13%) researcher) in one final group. PC relating to eligibility, recruitment, intervention and outcome acceptability and loss to follow-up were co-produced. Groups highlighted numerous means of adapting intervention and trial procedures should ‘change’ criteria be met. Modified NGT enabled the equal inclusion of patients, clinician and researcher in the co-production of PC. The structure and processes provided a transparent mechanism for setting PC that could be replicated in other feasibility studies.
- 6 October 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (19) , 3756
Open AccessCo-producing Progression Criteria for Feasibility Studies: A Partnership between Patient Contributors, Clinicians and Researchers
There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We describe a process for co-producing PC for an ongoing feasibility study. Patient contributors, clinicians and researchers participated in discussions facilitated using the modified Nominal Group Technique (NGT). Stage one involved individual discussion groups used to develop and rank PC for aspects of the trial key to feasibility. A second stage involving representatives from each of the individual groups then discussed and ranked these PC. The highest ranking PC became the criteria used. At each stage all members were provided with a brief education session to aid understanding and decision-making. Fifty members (15 (29%) patients, 13 (25%) researchers and 24 (46%) clinicians) were involved in eight initial groups, and eight (two (25%) patients, five (62%) clinicians, one (13%) researcher) in one final group. PC relating to eligibility, recruitment, intervention and outcome acceptability and loss to follow-up were co-produced. Groups highlighted numerous means of adapting intervention and trial procedures should ‘change’ criteria be met. Modified NGT enabled the equal inclusion of patients, clinician and researcher in the co-production of PC. The structure and processes provided a transparent mechanism for setting PC that could be replicated in other feasibility studies.